Corneal Cross-Linking: A Revolutionary Treatment for Keratoconus
Corneal cross-linking (CXL) is a groundbreaking treatment designed to prevent the progression of keratoconus, a condition where the cornea becomes cone-shaped and leads to significant vision impairment. Keratoconus occurs when the cornea is too flexible and begins to change shape, potentially resulting in progressive sight loss. Without intervention, patients may eventually require a corneal transplant.
Understanding the Cross-Linking Procedure
City Eye Surgeons offers this advanced cross-linking surgery to patients diagnosed with progressive keratoconus. The process begins with the application of local anaesthetic eye drops. The surface cells of the cornea are gently removed, and the cornea is then saturated with Vitamin B2 (riboflavin) drops. Ultraviolet (UV) light is applied to the cornea to activate the riboflavin, strengthening the corneal structure by increasing the cross-links between collagen fibres.
Why Choose City Eye Surgeons?
City Eye Surgeons stands out for several reasons when it comes to corneal cross-linking surgery:
Expertly trained surgeons with extensive experience in performing CXL.
A state-of-the-art facility equipped with the latest technology.
Personalised care plans tailored to each patient's unique needs.
A proven track record of successful outcomes.
Cross-linking surgery has been shown to significantly reduce the likelihood of requiring a corneal transplant, dropping the necessity from 20% to just 3%. Although CXL does not improve vision on its own, combining it with laser resurfacing can enhance the overall shape of the cornea, reducing the need for glasses or contact lenses in select cases.
To explore the benefits of corneal cross-linking and determine the proper treatment, contact City Eye Surgeons today to schedule a consultation.
Your vision deserves the best care.
